Search Results - "DESMEULES, Jules"

Refine Results
  1. 1

    Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature by Lenoir, Camille, Rollason, Victoria, Desmeules, Jules A., Samer, Caroline F.

    Published in Frontiers in pharmacology (16-11-2021)
    “…Background: Available in-vitro and animal studies indicate that inflammation impacts cytochromes P450 (CYP) activity via multiple and complex transcriptional…”
    Get full text
    Journal Article
  2. 2

    Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine by Marsousi, Niloufar, Desmeules, Jules A, Rudaz, Serge, Daali, Youssef

    Published in Journal of pharmaceutical sciences (01-09-2017)
    “…Personalized medicine aims to determine the most adequate treatment and dose regimen to obtain the maximum efficacy and minimum side effect by taking into…”
    Get more information
    Journal Article
  3. 3

    Gender Differences in Cardiovascular Pharmacotherapy-the Example of Hypertension: A Mini Review by Kalibala, Jacklean, Pechère-Bertschi, Antoinette, Desmeules, Jules

    Published in Frontiers in pharmacology (06-05-2020)
    “…Cardiovascular disease (CVD) is the leading cause of mortality worldwide in both sexes. Despite considerable progress in better understanding the patterns of…”
    Get full text
    Journal Article
  4. 4

    Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review by Lenoir, Camille, Rodieux, Frédérique, Desmeules, Jules A., Rollason, Victoria, Samer, Caroline F.

    Published in Clinical pharmacokinetics (01-12-2021)
    “…Background and Objective Cytochromes P450 (CYP) are the major enzymes involved in hepatic metabolism of drugs. Personalization of treatment in pediatrics is a…”
    Get full text
    Journal Article
  5. 5

    Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging Trends by Abouir, Kenza, Samer, Caroline F, Gloor, Yvonne, Desmeules, Jules A, Daali, Youssef

    Published in Frontiers in pharmacology (28-10-2021)
    “…Physiologically-based pharmacokinetics (PBPK) modeling is a robust tool that supports drug development and the pharmaceutical industry and regulatory…”
    Get full text
    Journal Article
  6. 6

    Is massage a legitimate part of nursing care? A qualitative study by Da Rocha Rodrigues, Gora, Anex, Adrien, Boegli, Monique, Bollondi Pauly, Catherine, Curtin, François, Luthy, Christophe, Desmeules, Jules, Cedraschi, Christine

    Published in PloS one (27-02-2023)
    “…The use of massage therapy has received increased attention in the treatment of chronic pain. However, barriers can hinder its use in nursing care. This study…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Prediction of drug‐drug interactions using physiologically‐based pharmacokinetic models of CYP450 modulators included in Simcyp software by Marsousi, Niloufar, Desmeules, Jules A., Rudaz, Serge, Daali, Youssef

    Published in Biopharmaceutics & drug disposition (01-01-2018)
    “…In recent years, physiologically based PharmacoKinetic (PBPK) modeling has received growing interest as a useful tool for the assessment of drug…”
    Get full text
    Journal Article
  9. 9

    Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a review by Rollason, Victoria, Samer, Caroline Flora, Daali, Youssef, Desmeules, Jules Alexandre

    Published in Current drug metabolism (01-03-2014)
    “…Non-steroidal anti-inflammatory drugs (NSAIDs) are the most frequently used drugs, either on prescription or over-thecounter (OTC). Their daily dosage is based…”
    Get more information
    Journal Article
  10. 10

    Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling by Magliocco, Gaëlle, Rodieux, Frédérique, Desmeules, Jules, Samer, Caroline Flora, Daali, Youssef

    Published in Pediatric research (01-02-2020)
    “…The activity of drug-metabolizing enzymes (DME) shows high inter- and intra-individual variability. Genetic polymorphisms, exposure to drugs, and environmental…”
    Get full text
    Journal Article
  11. 11

    Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect by Ing Lorenzini, Kuntheavy, Daali, Youssef, Fontana, Pierre, Desmeules, Jules, Samer, Caroline

    Published in Frontiers in pharmacology (19-12-2016)
    “…We report a patient who presented a non-ST segment elevation myocardial infarction in the context of severe normocytic hypochromic anemia related to…”
    Get full text
    Journal Article
  12. 12

    Physiologically‐Based Pharmacokinetic Modeling for the Prediction of CYP2D6‐Mediated Gene–Drug–Drug Interactions by Storelli, Flavia, Desmeules, Jules, Daali, Youssef

    “…The aim of this work was to predict the extent of Cytochrome P450 2D6 (CYP2D6)‐mediated drug–drug interactions (DDIs) in different CYP2D6 genotypes using…”
    Get full text
    Journal Article
  13. 13

    Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients by Pautex, Sophie, Bianchi, Federica, Daali, Youssef, Augsburger, Marc, de Saussure, Christian, Wampfler, James, Curtin, François, Desmeules, Jules, Broers, Barbara

    Published in Frontiers in aging neuroscience (29-09-2022)
    “…The management of behavioral symptoms and rigidity in patients with dementia constitutes a significant challenge. Short-term studies suggest an interest in the…”
    Get full text
    Journal Article
  14. 14

    Development of a predictive score for potentially avoidable hospital readmissions for general internal medicine patients by Blanc, Anne-Laure, Fumeaux, Thierry, Stirnemann, Jérôme, Dupuis Lozeron, Elise, Ourhamoune, Aimad, Desmeules, Jules, Chopard, Pierre, Perrier, Arnaud, Schaad, Nicolas, Bonnabry, Pascal

    Published in PloS one (15-07-2019)
    “…Identifying patients at high risk of hospital preventable readmission is an essential step towards selecting those who might benefit from specific transitional…”
    Get full text
    Journal Article
  15. 15

    Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children by Dilo, Ana, Daali, Youssef, Desmeules, Jules, Chalandon, Yves, Uppugunduri, Chakradhara R. S., Ansari, Marc

    Published in Therapeutic drug monitoring (01-02-2020)
    “…Busulfan (Bu) is one of the conditioning regimen components for pediatric hematopoietic stem cell transplantation. Bu therapeutic drug monitoring (TDM) is…”
    Get full text
    Journal Article
  16. 16

    Uncovering a Genetic Polymorphism Located in Huntingtin Associated Protein 1 in Modulation of Central Pain Sensitization Signaling Pathways by Gloor, Yvonne, Matthey, Alain, Sobo, Komla, Mouterde, Médéric, Kosek, Eva, Pickering, Gisèle, Poloni, Estella S., Cedraschi, Christine, Ehret, Georg, Desmeules, Jules A.

    Published in Frontiers in neuroscience (28-06-2022)
    “…Fibromyalgia syndrome (FMS) is characterized by widespread pain and increased sensitivity to nociceptive stimulus or tenderness. While familial aggregation…”
    Get full text
    Journal Article
  17. 17

    Outcomes of drug exposition during pregnancy: Analysis from a teratology information service by Lenoir, Camille, Boumaïza, Sabrina, Ing Lorenzini, Kuntheavy R, Boulvain, Michel, Desmeules, Jules A, Rollason, Victoria

    “…We aimed to characterize drug exposures during pregnancy where the outcome was known that had benefited from counselling through our Teratology Information…”
    Get full text
    Journal Article
  18. 18

    CYP450 Genotype—Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting by Ing Lorenzini, Kuntheavy, Desmeules, Jules, Rollason, Victoria, Bertin, Stéphane, Besson, Marie, Daali, Youssef, Samer, Caroline F.

    Published in Frontiers in pharmacology (26-08-2021)
    “…Pharmacokinetic variability is a major source of differences in drug response and can be due to genetic variants and/or drug-drug interactions. Cytochromes…”
    Get full text
    Journal Article
  19. 19

    Intestinal permeability and P-glycoprotein-mediated efflux transport of ticagrelor in Caco-2 monolayer cells by Marsousi, Niloufar, Doffey-Lazeyras, Fabienne, Rudaz, Serge, Desmeules, Jules A., Daali, Youssef

    Published in Fundamental & clinical pharmacology (01-12-2016)
    “…Ticagrelor is the unique reversible oral antiplatelet drug commercialized today. During this study, the intestinal permeability of ticagrelor and its potential…”
    Get full text
    Journal Article
  20. 20

    When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children by Rodieux, Frédérique, Vutskits, Laszlo, Posfay-Barbe, Klara M, Habre, Walid, Piguet, Valérie, Desmeules, Jules A, Samer, Caroline F

    Published in Frontiers in pharmacology (05-03-2018)
    “…Children represent a vulnerable population in which management of nociceptive pain is complex. Drug responses in children differ from adults due to age-related…”
    Get full text
    Journal Article